“Drug Pipeline”

32 result(s)
Drug Pipeline
Anticipating a Breakthrough Therapy for Type 1 Diabetes
Teplizumab: Potential Breakthrough Therapy for Type 1 Diabetes More
Briefing
Specialty
Integrated Solutions to Balance Cost and Access
Integrated specialty management solutions are crucial to balance cost and access More
Briefing
Cost Management
Strategy and Balance: Managing Costs for Pulmonary Arterial Hypertension
Managing Treatment Costs for Pulmonary Arterial Hypertension More
Briefing
Cost Management
A Breath of Fresh Air for Patients with Pulmonary Arterial Hypertension
New Dry Powder Inhalation Therapies for PAH in Pipeline More
Briefing
Drug Pipeline
More Treatments, Costs for Patients with Inflammatory Bowel Disease
As more treatments for inflammatory bowel disease are approved, payors can counter cost increases with comprehensive utilization management. More
Briefing
Drug Pipeline
Expanding Therapies, Indications and Implications for Payors
2022 Marketplace Outlook: Expanding Therapies, Indications and Implications for Payors More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline More
Briefing
Drug Pipeline
New Migraine Drugs Near Approval
... More
Briefing
Cost Management
Assessing New-to-Market Biologics and Biosimilars
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications. More
Commentary
Specialty
Diabetes Medications for Management of Obesity
Medications that have been used to treat diabetes are now being used for weight loss in patients without diabetes. But do the outcomes justify the costs? More
Briefing